Document:

<PAGE>   1
                                                                    Exhibit 10.4

                             STOCK OPTION AGREEMENT

         THIS STOCK OPTION AGREEMENT between PROVANT, Inc., a Delaware
corporation (the "Company"), and Curtis M. Uehlein (the "Grantee") dated
effective as of October 8, 1999 (the "Date of Grant").

         For good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged, the parties hereto act and agree as follows:

Section 1.        The Plan

         The option granted pursuant to this Agreement is not granted pursuant
to the Company's 1998 Equity Incentive Plan (the "Plan"). This Agreement shall
nevertheless be subject to the terms of the Plan, a copy of which is attached
hereto as Exhibit A and is incorporated herein in its entirety, except to the
extent this Agreement and the Plan or any agreement between the Company and the
Grantee are in conflict, in which case this Agreement or such other agreement
shall control. Capitalized terms used herein and not otherwise defined shall
have the meanings ascribed to them in the Plan.

Section 2.        Grant of Option

         The Company hereby grants to the Grantee, as of the Date of Grant, an
option (the "Option") to purchase up to 225,000 shares of Common Stock, par
value $.01 per share, of the Company (the "Option Shares") at a price per share
of $16.375, both the price and the number of shares being subject to adjustment
only as provided herein and in the Plan.

Section 3.        Terms of Option

         Subject to such further limitations as are provided herein, the Option
shall be exercisable in three (3) installments, with the Grantee having the
right hereunder to purchase from the Company the following number of Option
Shares upon exercise of the Option, on and after the following dates, in
cumulative fashion:

                  (a) on and after the first anniversary of the Date of Grant,
         up to one-third (ignoring fractional shares) of the total number of
         Option Shares;

                  (b) on and after the second anniversary of the Date of Grant,
                  up to an additional one-third (ignoring fractional shares) of
                  the total number of Option Shares; and

                  (c) on and after the third anniversary of the Date of Grant,
         the remaining Option Shares.
<PAGE>   2
Section 4.        Termination of the Option

         The Option and all rights hereunder with respect thereto, to the extent
such rights shall not have been exercised, shall terminate and become null and
void after the close of business on the day that is seven (7) years from the
Date of Grant (the "Option Term").

Section 5.        Cessation of Grantee's Employment

         (a) If the Grantee ceases to be employed by the Company by reason of
the Grantee's death during the Option Term, the Option shall be exercisable, to
the extent the Option was exercisable on the date of the Grantee's death, either
by the Grantee's executor or administrator or, if not so exercised, by the
legatees or distributees of the Grantee's estate, only during the twelve (12)
months immediately following the Grantee's death, after which time the Option
shall terminate.

         (b) If the Grantee ceases to be employed by the Company during the
Option Term for any other reason, the Option (i) to the extent that it is not
then exercisable by the Grantee shall terminate on the date the Grantee's
employment with the Company ceased, and (ii) to the extent that it was
exercisable on the date the Grantee's employment with the Company ceased shall
continue to be exercisable during the thirty (30) days immediately following
such cessation, after which time the Option shall terminate.

         (c) Notwithstanding any other provisions set forth herein or in the
Plan, in no event shall the Option be exercised after the expiration of the
Option Term.

         (d) Notwithstanding any other provisions set forth herein or in the
Plan, the Option shall terminate automatically and without notice to the Grantee
on the date the Grantee's employment is terminated for "cause". For the purposes
hereof, "cause" shall mean any conduct that the Board of Directors of the
Company determines in good faith impairs the reputation, goodwill or business of
the Company or any of its subsidiaries or is inimical to the best interests of
the Company or any of its subsidiaries. A termination for "cause" will include
any resignation in anticipation of discharge for "cause" or accepted by the
Company in lieu of a formal discharge for "cause".

Section 6.        Exercise of Option

         (a) The Grantee may exercise the Option with respect to all or any part
of the number of Option Shares then exercisable hereunder by giving written
notice of election to the Company, attention: Treasurer. Such notice shall
specify the number of Option Shares with respect to which the Option is to be
exercised.

         (b) At the time the Option is exercised, the Grantee shall make full
payment for the Option Shares purchased, in cash, certified check or bank
cashier's check, or, with the prior

                                       -2-
<PAGE>   3
written consent of the Company, in whole or in part through the surrender of
shares of Common Stock having a fair market value equal to the exercise price,
through delivery of a note or pursuant to any cashless exercise program that the
Company may adopt. The Grantee also shall pay to the Company or make provision
satisfactory to the Company for the payment of any taxes required by law to be
withheld by the Company at the time of the exercise of the Option or the sale of
the Option Shares acquired upon such exercise. For purposes of this Section 6(b)
and Section 6(c) below, "fair market value" shall be determined based on the
last sale price of the Common Stock as reported by the principal national
securities exchange or automated quotation system on which the Common Stock is
listed on the date of exercise.

         (c) In the event exercise of the Option otherwise would require the
Company to issue a fractional share of Common Stock of the Company, except as
otherwise provided below, such fraction shall be disregarded and the purchase
price payable in connection with such exercise shall be appropriately reduced.
Any such fractional share shall be carried forward and added to any shares
covered by future exercise(s) of the Option.

         (d) Notwithstanding anything to the contrary contained herein, the
Option shall not be exercisable unless either (a) a registration statement under
the Securities Act of 1933, as amended, with respect to the Option Shares shall
have become, and continues to be, effective, or (b) the Grantee (i) shall have
represented, warranted and agreed, in form and substance satisfactory to the
Company, at the time of exercising the Option, that the Grantee is acquiring the
Option Shares for the Grantee's own account, for investment and not with a view
to or in connection with any distribution, (ii) shall have agreed to
restrictions on transfer in form and substance satisfactory to the Company, and
(iii) shall have agreed to an endorsement which makes appropriate reference to
such representations, warranties, agreements and restrictions on the
certificate(s) representing the Option Shares.

Section 7.        No Rights of a Stockholder

         Neither the Grantee nor any personal representative shall be, or shall
have any of the rights and privileges of, a stockholder of the Company with
respect to any Option Shares, in whole or in part, prior to the date of exercise
of the Option.

Section 8.        Nontransferability of Option

         During the Grantee's lifetime, unless otherwise allowed by the Board of
Directors of the Company pursuant to Section 6.4 of the Plan, the Option shall
be exercisable only by the Grantee, and the Option shall not in any event be
transferable except, in case of the death of the Grantee, by will or the laws of
descent and distribution.

                                       -3-
<PAGE>   4
Section 9.        Employment Not Affected

         Neither the granting of the Option nor its exercise shall be construed
as granting to the Grantee any right with respect to the Grantee's continued
employment by the Company. Except as may otherwise be limited by a written
agreement between the Company and the Grantee, the right of the Company to
terminate at will the Grantee's employment at any time (whether by dismissal,
discharge, retirement or otherwise) is specifically reserved by the Company.

Section 10.       Amendment of Option

         The Option may be amended or modified at any time by the Company;
provided, however, that the Grantee's consent to such amendment or modification
shall be required unless the Board of Directors or Compensation Committee (if
any) of the Company determines that the amendment or modification, taking into
account any related action, would not materially and adversely affect the
Grantee.

Section 11.       Notice

         (a) Any notices required or permitted hereunder shall be addressed to
the Company at 67 Batterymarch Street, Suite 400, Boston, Massachusetts 02110,
Attention: Treasurer, or to the Grantee at the most current address of the
Grantee appearing in the records of the Company, as the case may be.

         (b) Either the Company or the Grantee may, by notice to the other given
in the manner provided in Section 11(a), change the designated address for
future notice.

Section 12.       Governing Law

         The validity, construction, interpretation and effect of this
instrument shall be governed by and determined in accordance with the law of the
Commonwealth of Massachusetts, without regard to conflicts of law principles.

                                       -4-
<PAGE>   5
         IN WITNESS WHEREOF, the Company has caused this Agreement to be duly
executed by its officer thereunto duly authorized and the Grantee has hereunto
set his hand all as of the 8th day of October 1999.

                                  PROVANT, INC.

                                  By: /s/ Rajiv Bhatt
                                     -------------------------------------------
                                      Its: Executive Vice President

                                  ACCEPTED:

                                      /s/ Curtis M. Uehlein
                                     -------------------------------------------
                                      Curtis M. Uehlein, Grantee

                                       -5-<PAGE>   1

                                                                   EXHIBIT 10.62

                       AMENDMENT NO. 1 TO RIGHTS AGREEMENT

           This Amendment No. 1 dated December 9, 1999 hereby amends the Rights
Agreement dated as of January 23, 1992 (the "Agreement"), between PolyMedica
Corporation (then PolyMedica Industries, Inc.), a Massachusetts corporation (the
"Company"), and BankBoston, N.A. (then The First National Bank of Boston), a
national banking association, as Rights Agent (the "Rights Agent").

                              W I T N E S S E T H:

         WHEREAS, no Person has become an Acquiring Person as such terms are
defined in the Agreement; and

         WHEREAS, the Company has directed the Rights Agent to enter into this
Amendment No. 1 pursuant to Section 27 of the Agreement;

         NOW, THEREFORE, in consideration of the premises and mutual agreements
set forth herein, the parties hereby agree as follows:

1.       Section 1(a) of the Agreement is hereby deleted in its entirety and the
following substituted in lieu thereof:

                  (a) "Acquiring Person" shall mean any Person who or which,
                  together with all Affiliates and Associates of such Person,
                  shall be the Beneficial Owner of 15% or more of the shares of
                  Common Stock then outstanding, but shall not include (i) the
                  Company, (ii) any Subsidiary of the Company, (iii) any
                  employee benefit plan of the Company or of any Subsidiary of
                  the Company, or any Person or entity organized, appointed or
                  established by the Company for or pursuant to the terms of any
                  such plan, (iv) any such Person who becomes the beneficial
                  owner of 15% or more of the shares of Common Stock then
                  outstanding as a result of a reduction in the number of shares
                  of Common Stock outstanding due to the repurchase of shares of
                  Common Stock by the Company unless and until such Person,
                  after becoming aware that such Person has become the
                  Beneficial Owner of 15% or more of the then outstanding shares
                  of Common Stock, acquires beneficial ownership of additional
                  shares of Common Stock representing 1% or more of the shares
                  of Common Stock then outstanding or (v) an Exempted Person.
                  Notwithstanding the foregoing, if the Board of Directors of
                  the Company determines in good faith that a Person who would
                  otherwise be an "Acquiring Person," as defined pursuant to the
                  foregoing provisions of this paragraph (a), has become such
                  inadvertently, and such Person divests as promptly as
                  practicable a sufficient number of shares of Common

                                       26

<PAGE>   2

                  Stock so that such Person would no longer be the Beneficial
                  Owner of 10% or more of the shares of Common Stock then
                  outstanding, then such Person shall not be deemed to be an
                  "Acquiring Person" for any purposes of this Agreement unless
                  and until such Person shall again become an "Acquiring
                  Person."

2.       Section 1 of the Agreement is hereby further amended by adding new
paragraph (m-1), immediately after paragraph (m), as follows:

                  (m-1)    "Exempted Person" shall mean SAFECO Common Stock
                           Trust, SAFECO Resource Series Trust, SAFECO Asset
                           Management Company and SAFECO Corporation
                           (collectively, "SAFECO"), unless and until such time
                           as SAFECO, together with its Affiliates, directly or
                           indirectly, becomes the Beneficial Owner of 20% or
                           more of the Common Stock then outstanding, in which
                           event SAFECO immediately shall cease to be an
                           Exempted Person.

3.       Section 11(a)(ii))B) of the Agreement is hereby deleted and the
following substituted in lieu thereof:

                  (B)      any Person (other than the Company, any Subsidiary of
                           the company, any employee benefit plan of the Company
                           or of any Subsidiary of the Company, or any Person or
                           entity organized, appointed or established by the
                           Company for or pursuant to the terms of any such
                           plan), alone or together with its Affiliates and
                           Associates, shall, at any time after the Rights
                           Dividend Declaration Date, become the Beneficial
                           Owner of 15% or more (or, in the case of an Exempted
                           Person, 20% or more) of the shares of Common Stock
                           then outstanding, unless the event causing the 15%
                           threshold (or in the case of an Exempted Person, the
                           20% threshold) to be crossed is a transaction set
                           forth in Section 13(a) hereof, or is an acquisition
                           of shares of Common Stock pursuant to a tender offer
                           or an exchange offer for all outstanding shares of
                           Common Stock at a price and on terms determined by at
                           least a majority of the members of the Board of
                           Directors who are not officers of the Company and who
                           are not representatives, nominees, Affiliates or
                           Associates of an Acquiring Person, after receiving
                           advice from a nationally recognized investment
                           banking firm selected by the Board of Directors of
                           the Company, to be (a) at a price that is fair to
                           stockholders (taking into account all factors which
                           such members of the Board deem relevant including,
                           without limitation, prices which could reasonably be
                           achieved if the Company or its assets were sold on an
                           orderly basis designed to realize maximum value) and
                           (b) otherwise in the best interests of the Company
                           and its stockholders, or

                                       27

<PAGE>   3

           IN WITNESS WHEREOF, the parties have caused this Amendment No. 1 to
be duly executed and their respective corporate seals to be hereunto affixed and
attested as of the day and year first written above.

                             POLYMEDICA CORPORATION

Attest:

/s/ Eric G. Walters                        /s/ Steven J. Lee
_____________________________          By:______________________________________
Name:  Eric G. Walters                 Name:  Steven J. Lee
Title: Chief Financial Officer         Title: Chairman of the Board
                                              and Chief Executive Officer
Seal

                                       BANKBOSTON, N.A.
Attest:

/s/ Patricia A. DeLuca                     /s/ Joshua P. McGinn
______________________________         By:______________________________________
Name:  Patricia A. DeLuca                 Name:  Joshua P. McGinn
Title: Account Manager                    Title: Senior Account Manager

                                       28

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}]]